Literature DB >> 20813844

Homotypic cell to cell cross-talk among human natural killer cells reveals differential and overlapping roles of 2B4 and CD2.

Eun-Ok Kim1, Tae-Jin Kim, Nayoung Kim, Sung Tae Kim, Vinay Kumar, Kyung-Mi Lee.   

Abstract

Human natural killer (NK) cells express an abundant level of 2B4 and CD2 on their surface. Their counter-receptors, CD48 and CD58, are also expressed on the NK cell surface, raising a question about the functional consequences of potential 2B4/CD48 and CD2/CD58 interactions. Using blocking antibodies specific to each receptor, we demonstrated that both 2B4/CD48 and CD2/CD58 interactions were essential for the development of NK effector functions: cytotoxicity and cytokine secretion. However, only 2B4/CD48, but not CD2/CD58, interactions were shown to be critical for the optimal NK cell proliferation in response to interleukin (IL)-2. IL-2-activated NK cells cultured in the absence of 2B4/CD48 or CD2/CD58 interactions were severely impaired for their ability to induce intracellular calcium mobilization and subsequent ERK activation upon tumor target exposure, suggesting that the early signaling pathway of NK receptors leading to impaired cytolysis and interferon (IFN)-γ secretion was inhibited. Nevertheless, these defects did not fully account for the reduced proliferation of NK cells in the absence of 2B4/CD48 interactions, because anti-CD2 or anti-CD58 monoclonal antibody (mAb)-treated NK cells, showing defective signaling and effector functions, displayed normal proliferation upon IL-2 stimulation. These results propose the signaling divergence between pathways leading to cell proliferation and cytotoxicity/cytokine release, which can be differentially regulated by 2B4 and CD2 during IL-2-driven NK cell activation. Collectively, these results reveal the importance of homotypic NK-to-NK cell cross-talk through 2B4/CD48 and CD2/CD58 pairs and further present their differential and overlapping roles in human NK cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20813844      PMCID: PMC3009903          DOI: 10.1074/jbc.M110.137976

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  42 in total

Review 1.  Of mice and men: different functions of the murine and human 2B4 (CD244) receptor on NK cells.

Authors:  Swapnil V Vaidya; Porunelloor A Mathew
Journal:  Immunol Lett       Date:  2006-03-15       Impact factor: 3.685

2.  Molecular basis for positive and negative signaling by the natural killer cell receptor 2B4 (CD244).

Authors:  Philipp Eissmann; Lisa Beauchamp; Joe Wooters; John C Tilton; Eric O Long; Carsten Watzl
Journal:  Blood       Date:  2005-02-15       Impact factor: 22.113

3.  2B4 (CD244), NTB-A and CRACC (CS1) stimulate cytotoxicity but no proliferation in human NK cells.

Authors:  Sebastian Stark; Carsten Watzl
Journal:  Int Immunol       Date:  2006-01-12       Impact factor: 4.823

4.  CD28-stimulated ERK2 phosphorylation is required for polarization of the microtubule organizing center and granules in YTS NK cells.

Authors:  Xi Chen; David S J Allan; Konrad Krzewski; Baoxue Ge; Hernan Kopcow; Jack L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-26       Impact factor: 11.205

5.  2B4/CD48-mediated regulation of lymphocyte activation and function.

Authors:  Erika Assarsson; Taku Kambayashi; Catrine M Persson; Benedict J Chambers; Hans-Gustaf Ljunggren
Journal:  J Immunol       Date:  2005-08-15       Impact factor: 5.422

6.  The adaptor protein 3BP2 binds human CD244 and links this receptor to Vav signaling, ERK activation, and NK cell killing.

Authors:  Ifigènia Saborit-Villarroya; Juana M Del Valle; Xavier Romero; Enric Esplugues; Pilar Lauzurica; Pablo Engel; Margarita Martín
Journal:  J Immunol       Date:  2005-10-01       Impact factor: 5.422

7.  Requirement of homotypic NK-cell interactions through 2B4(CD244)/CD48 in the generation of NK effector functions.

Authors:  Kyung-Mi Lee; John P Forman; Megan E McNerney; Susan Stepp; Sumalatha Kuppireddi; Dustin Guzior; Yvette E Latchman; Mohamed H Sayegh; Hideo Yagita; Chul-Kyu Park; Seog Bae Oh; Christoph Wülfing; John Schatzle; Porunelloor A Mathew; Arlene H Sharpe; Vinay Kumar
Journal:  Blood       Date:  2005-05-19       Impact factor: 22.113

8.  Targeted disruption of the 2B4 gene in mice reveals an in vivo role of 2B4 (CD244) in the rejection of B16 melanoma cells.

Authors:  Swapnil V Vaidya; Susan E Stepp; Megan E McNerney; Jae-Kyung Lee; Michael Bennett; Kyung-Mi Lee; Colin L Stewart; Vinay Kumar; Porunelloor A Mathew
Journal:  J Immunol       Date:  2005-01-15       Impact factor: 5.422

Review 9.  2B4 (CD244) is a non-MHC binding receptor with multiple functions on natural killer cells and CD8+ T cells.

Authors:  Megan E McNerney; Kyung-Mi Lee; Vinay Kumar
Journal:  Mol Immunol       Date:  2005-02       Impact factor: 4.407

10.  CD48 stimulation by 2B4 (CD244)-expressing targets activates human NK cells.

Authors:  Birgitta Messmer; Philipp Eissmann; Sebastian Stark; Carsten Watzl
Journal:  J Immunol       Date:  2006-04-15       Impact factor: 5.422

View more
  13 in total

Review 1.  Evolving immune circuits are generated by flexible, motile, and sequential immunological synapses.

Authors:  Audrey Gérard; Peter Beemiller; Rachel S Friedman; Jordan Jacobelli; Matthew F Krummel
Journal:  Immunol Rev       Date:  2013-01       Impact factor: 12.988

2.  Semaphorin 7A modulates cytokine-induced memory-like responses by human natural killer cells.

Authors:  Joshua Ghofrani; Olivier Lucar; Haley Dugan; R Keith Reeves; Stephanie Jost
Journal:  Eur J Immunol       Date:  2019-05-02       Impact factor: 5.532

3.  2B4 Mediates Inhibition of CD8+ T Cell Responses via Attenuation of Glycolysis and Cell Division.

Authors:  Sonia J Laurie; Danya Liu; Maylene E Wagener; Phoebe C Stark; Cox Terhorst; Mandy L Ford
Journal:  J Immunol       Date:  2018-07-16       Impact factor: 5.422

4.  Preventive Anti-CD2 Treatment does not Impair Parasite Control in a Murine Toxoplasmosis Model.

Authors:  U Erben; N N Pawlowski; M M Heimesaat; C Loddenkemper; K Doerfel; S Spieckermann; B Siegmund; A A Kühl
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2015-11-12

5.  The DC-SIGN-CD56 interaction inhibits the anti-dendritic cell cytotoxicity of CD56 expressing cells.

Authors:  Alexey A Nabatov; Ivan S Raginov
Journal:  Infect Agent Cancer       Date:  2015-12-10       Impact factor: 2.965

6.  Differential expression of proteins in naïve and IL-2 stimulated primary human NK cells identified by global proteomic analysis.

Authors:  Weifeng Cao; Arvinder Kapur; Di Ma; Mildred Felder; Cameron O Scarlett; Manish S Patankar; Lingjun Li
Journal:  J Proteomics       Date:  2013-06-25       Impact factor: 4.044

7.  Augmentation of natural cytotoxicity by chronic low-dose ionizing radiation in murine natural killer cells primed by IL-2.

Authors:  Chung Hee Sonn; Jong Rip Choi; Tae-Jin Kim; Young-Bin Yu; Kwanghee Kim; Suk Chul Shin; Gil-Hong Park; Toshiro Shirakawa; Hee Sun Kim; Kyung-Mi Lee
Journal:  J Radiat Res       Date:  2012-08-21       Impact factor: 2.724

8.  CD2 promotes human natural killer cell membrane nanotube formation.

Authors:  Colin J Comerci; Emily M Mace; Pinaki P Banerjee; Jordan S Orange
Journal:  PLoS One       Date:  2012-10-24       Impact factor: 3.240

9.  The tetraspanin CD53 modulates responses from activating NK cell receptors, promoting LFA-1 activation and dampening NK cell effector functions.

Authors:  Izabela Todros-Dawda; Lise Kveberg; John T Vaage; Marit Inngjerdingen
Journal:  PLoS One       Date:  2014-05-15       Impact factor: 3.240

10.  Nurse-like cells promote CLL survival through LFA-3/CD2 interactions.

Authors:  Loic Ysebaert; Mary Poupot; Frédéric Boissard; Marie Tosolini; Laetitia Ligat; Anne Quillet-Mary; Frederic Lopez; Jean-Jacques Fournié
Journal:  Oncotarget       Date:  2016-11-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.